Lenia

Lactobacillus rhamnosus, the active ingredient in Lenia, is a probiotic presented as a dietary supplement for oral use. It is intended to help maintain a balanced intestinal microbiota and support overall digestive health. GNH USA supplies Lenia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lenia, containing Lactobacillus rhamnosus, is used to support gastrointestinal health and related microbial balance. - Antibiotic‑associated diarrhea: helps preserve normal gut flora during and after antibiotic therapy. - Irritable bowel syndrome: may reduce abdominal discomfort and improve stool regularity. - Vaginal health: contributes to a healthy vaginal microbiome and may lessen recurrence of bacterial vaginosis. - Immune modulation: supports normal immune function by interacting with gut‑associated lymphoid tissue. - Infant colic: may alleviate crying episodes in formula‑fed infants by modulating gut bacteria.

Lactobacillus rhamnosus is generally well tolerated, but some users may experience mild adverse reactions.

Common Side Effects: - Bloating: transient abdominal distension. - Gas: increased flatulence. - Nausea: mild queasiness. - Diarrhoea: occasional loose stools. - Constipation: occasional difficulty passing stool.

Serious or Rare Side Effects: - Sepsis: rare bloodstream infection, primarily in severely immunocompromised individuals. - Allergic reaction: rash, itching, or swelling. - Fungal overgrowth: uncommon, may occur with prolonged use. - Respiratory infection: very rare, reported in case studies.

Before using Lenia, consider the following safety measures. - Pregnancy and lactation: consult a healthcare professional before use. - Immunocompromised patients: use with caution and under medical supervision. - Concurrent antibiotic therapy: may reduce probiotic viability; consider timing of doses. - Age restrictions: not intended for children under one year unless advised by a clinician. - Known allergies: discontinue if hypersensitivity to Lactobacillus species occurs. - Store below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Lactobacillus rhamnosus may interact with certain medications; monitoring is advised.

Major Interactions (Avoid): - Antibiotics: can diminish probiotic effectiveness by killing the bacteria. - Immunosuppressants: increase risk of opportunistic infection.

Moderate Interactions (Monitor Closely): - Antifungal agents: may alter probiotic colonisation. - Proton pump inhibitors: reduced gastric acidity can affect bacterial survival. - Other probiotic products: potential competition for gut niches. - Antidiarrhoeal agents: may modify gut motility influencing probiotic action.